Quidel

News Release

Printer Friendly Version View printer-friendly version << Back
March 7, 2002 at 1:12 PM EST

Quidel to Present at SG Cowen 22nd Annual Health Care Conference, March 12, 2002

SAN DIEGO, March 7 /PRNewswire-FirstCall/ -- Quidel Corporation (Nasdaq: QDEL), a leading provider of rapid point-of-care (POC) diagnostic tests, today announced that its President and Chief Executive Officer, S. Wayne Kay, and its Chief Financial Officer, Paul E. Landers, will present at the SG Cowen 22nd Annual Health Care Conference, to be held in Boston, MA.

Quidel management will present on Tuesday, March 12, 2002 at 8:00 a.m. ET and also on March 12 at 9:00 a.m. ET. The conference will take place at The Marriott Copley Place Hotel, Boston.

About Quidel

Quidel Corporation discovers, develops, manufactures and markets rapid point-of-care diagnostic tests for detection of medical conditions and illnesses. These products provide accurate, rapid and cost-effective diagnostic information for acute and chronic conditions associated with women's health, in areas such as reproduction and diseases of the elderly. Quidel also provides point-of-care diagnostics for infectious diseases, including influenza A and B, strep throat, H. pylori infection, chlamydia, infectious mononucleosis and bacterial vaginosis. Quidel's products are sold to healthcare professionals for use in physicians' offices, clinical laboratories and pharmacies, and to consumers through organizations that provide private label, store brand products. These tests provide diagnostic information to enable rapid treatment and improve health outcomes, lower costs and increase patient satisfaction. For more information, please visit Quidel's Web site at www.quidel.com .

CONTACT:
Martin Halsall, mhalsall@lhai.com, or Bruce Voss,
bvoss@lhai.com, of Lippert/Heilshorn & Associates, +1-310-691-7100, for
Quidel Corporation; or Paul E. Landers, Vice President & CFO of
Quidel Corporation, +1-858-552-7962